Our
Story

Karren-Lee Addictionology® is the only clinical practice that effectively deals with use and abuse of processed foods. The company’s founder Dr Raymond is an accomplished, motivated author, clinician, academic, and researcher publishing in high-impact medical journals.

Meet the founder. Dr Karren-Lee Raymond

Dr Karren-Lee Raymond’s academic profile includes a B. Soc. Sc. (Psych) Hons (1st class) USC; B. Beh. Sc (Psych) QUT; Dip. Couns, (Counselling College of Australia).

Karren-Lee’s research focuses on the processed food addiction concept being a neurobiochemical condition of the brain, and prevention and treatment of processed food addiction is the same as treating other addictive diseases such as alcoholism and drug addiction.

Through treatment based on abstinence from the addictive substance – processed foods, processed food addicts can live happy and healthy lives.

Academic & industry publications

Raymond, K-L., & Lovell, G. P. (2015). Food addiction symptomology, impulsivity, mood, and body mass index in people with type two diabetes. Appetite, 95, 383-389, doi:10.1016/j.appet.2015.07.030

Raymond, K-L., & Lovell, G. P. (2016). Food Addiction Associations with Psychological Distress among People with Type 2 Diabetes. Journal of Diabetes and its Complications. 30, 651-656, doi: 10.1016/j.jdiacomp.2016.01.020

Raymond, K-L., Kannis-Dymand, L., & Lovell, G. P. (2016). A graduated food addiction classification approach significantly differentiates obesity among people with type 2 diabetes. Journal of Health Psychology, 1-10, doi: 10.1177/1359105316672096

Raymond, K-L., Kannis-Dymand, L., & Lovell, G. P. (2017). A Graduated Food Addiction Classifications Approach Significantly Differentiates Depression, Anxiety and Stress among People with Type 2 Diabetes. Completed – currently in review – Diabetes Research and Clinical Practice. 132, 95-101 http://dx.doi.org/10.1016/j.diabres.2017.07.028

Raymond, K-L., Kannis-Dymand, L., & Lovell, G. P. (2017). Impulsivity, Processed Food Addiction Classifications and Type 2 Diabetes: Implementation of a Standardised Clinical Screening Battery, employing Mild, Moderate or Severe Severity Levels. Currently ready for submission (Research shared at ISAM 2017 UAE Abu Dhabi).